Replies to post #15504 on Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Jess, I'm not sure that I understand your post.....

I believe there are 2 separate lawsuits, one involving the 2037 patent for Lupkynis and the other involving 2 patents for VOS, their DES drug.

However, Aurinia is suing Sun and its Cequa dry eye medicine approved in 2018 over two patents from its voclosporin ophthalmic solution. Aurinia revealed the suit in December 2020 claims Sun’s dry eye med Cequa, or cyclosporine, infringes on two of its patents and is asking for an injunction to stop Sun from selling Cequa and monetary relief including cost. Sun has denied the charges and said the two patents at issue are invalid. That case is expected to go to trial in March 2023.

https://endpts.com/aurinia-faces-choppy-waters-amid-lower-than-expected-2022-guidance-and-patent-challenge-on-lupkynis/